134 related articles for article (PubMed ID: 26118190)
21. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of p53 protein expression in renal cell carcinoma: comparison of two antibodies.
Walsh CJ; Kay EW; Lynch T; Walsh M; Milburn C; McLean PA; Murphy D; Donovan M; Leader MB
Br J Biomed Sci; 1996 Sep; 53(3):179-81. PubMed ID: 8914341
[TBL] [Abstract][Full Text] [Related]
23. Investigation of tumour supressor protein p53 in renal cell carcinoma patients.
Hodorova I; Solar P; Mihalik J; Vecanova J; Adamkov M; Rybarova S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):44-9. PubMed ID: 23073516
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma.
Iwamura M; Wu W; Muramoto M; Ohori M; Egawa S; Uchida T; Baba S
Cancer; 1999 Sep; 86(6):1028-34. PubMed ID: 10491530
[TBL] [Abstract][Full Text] [Related]
25. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
26. Tissue Micro Arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma.
Scognamiglio G; Cantile M; Scala S; Cecere S; Russo F; Collina F; Marra L; Sabbatino F; Botti G; Franco R
Int J Clin Exp Pathol; 2014; 7(4):1814-8. PubMed ID: 24817986
[No Abstract] [Full Text] [Related]
27. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
[TBL] [Abstract][Full Text] [Related]
28. Immunoexpression of napsin A in renal neoplasms.
Zhu B; Rohan SM; Lin X
Diagn Pathol; 2015 Mar; 10():4. PubMed ID: 25889632
[TBL] [Abstract][Full Text] [Related]
29. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.
Ronkainen H; Vaarala MH; Kauppila S; Soini Y; Paavonen TK; Rask J; Hirvikoski P
Oncol Rep; 2009 Jun; 21(6):1519-23. PubMed ID: 19424632
[TBL] [Abstract][Full Text] [Related]
30. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
Alfaro CM; Jarmusch AK; Pirro V; Kerian KS; Masterson TA; Cheng L; Cooks RG
Anal Bioanal Chem; 2016 Aug; 408(20):5407-14. PubMed ID: 27206411
[TBL] [Abstract][Full Text] [Related]
31. Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Patraki E; Cardillo MR
Int J Immunopathol Pharmacol; 2007; 20(4):697-705. PubMed ID: 18179742
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of tissue microarrays.
Simon R; Mirlacher M; Sauter G
Methods Mol Biol; 2010; 664():113-26. PubMed ID: 20690058
[TBL] [Abstract][Full Text] [Related]
33. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
Kuo JY; Chang KM; Chen KK; Chang LS
Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
[TBL] [Abstract][Full Text] [Related]
34. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.
Zhang X; Takenaka I
Urology; 2000 Sep; 56(3):510-5. PubMed ID: 10962335
[TBL] [Abstract][Full Text] [Related]
35. Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D.
Hedberg Y; Davoodi E; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2002 Dec; 102(6):601-7. PubMed ID: 12448001
[TBL] [Abstract][Full Text] [Related]
36. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
Gokden N; Gokden M; Phan DC; McKenney JK
Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
38. Assessing expression of apoptotic markers using large cohort tissue microarrays.
Pick E; McCarthy MM; Kluger HM
Methods Mol Biol; 2008; 414():83-93. PubMed ID: 18175814
[TBL] [Abstract][Full Text] [Related]
39. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody.
Hu Y; Hartmann A; Stoehr C; Zhang S; Wang M; Tacha D; Montironi R; Lopez-Beltran A; Cheng L
J Clin Pathol; 2012 Mar; 65(3):254-6. PubMed ID: 22135028
[TBL] [Abstract][Full Text] [Related]
40. Impact of Gender in Renal Cell Carcinoma: The Relationship of FABP7 and BRN2 Expression with Overall Survival.
Tan C; Takayama T; Takaoka N; Fujita H; Miyazaki M; Sugiyama T; Ozono S
Clin Med Insights Oncol; 2014; 8():21-7. PubMed ID: 24653654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
